Share
Phosphorex Helps a Gene-Editing Biotech Establish Lipid Nanoparticle R&D through Contract FTE Services Saving $2.2M
Introduction
In this success story, learn how Phosphorex helped a preclinical biotechnology company rapidly establish lipid nanoparticle R&D capabilities without the time and expense required to build an internal team. Through flexible contract FTE services, Phosphorex provided dedicated formulation and analytical expertise, prepared hundreds of unique LNPs and targeted LNPs, and generated the test articles needed to support the company’s gene-editing research, saving an estimated $2.2 million in the first year.
“Working with Phosphorex was the easiest partnership I’ve ever had. One of the things I really appreciated was that as soon as data was available, we would get results, and the quality of the documentation was extremely impressive.”
VP, Platform and Delivery
Emerging Biotech